Download PDF
Synthesis 2010(24): 4287-4299  
DOI: 10.1055/s-0030-1258967
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Novel, Versatile Three-Step Synthesis of 1,2,3,4,10,10a-Hexahydro­pyrazino[1,2-a]indoles by Intramolecular Carbene-Mediated C-H Insertion

Niels Krogsgaard-Larsena, Mikael Begtrupa, Matthias M. Hertha, Jan Kehler*b
a Department of Medicinal Chemistry, The Faculty of Pharmaceutical Sciences, University of Copenhagen, 2 Universitetsparken, 2100 Copenhagen, Denmark
b H. Lundbeck A/S, Department of Medicinal Chemistry, 9 Ottiliavej, 2500 Valby, Denmark
Fax: +45 36438237; e-Mail: jke@lundbeck.com;
Further Information

Publication History

Received 31 August 2010
Publication Date:
09 November 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

A new convenient three-step synthesis of the privileged CNS scaffold 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles has been developed. The method makes use of an intramolecular carbene-mediated C-H insertion in phenylpiperazine-derived tosyl­hydrazones made from 2-fluorobenzaldehydes. Notably, the piperazine can be replaced with other cyclic nitrogen bases and the methodology is successfully extended to pyrrolidine, piperidine, azepane, morpholine, and homopiperazine.

Key words

1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles - C-H insertion - phenylpiperazine - carbene - cyclization

    References

  • 1a Lloyd EJ. Andrews PR. J. Med. Chem.  1986,  29:  453 
    Google Scholar
  • 1b Wager TT. Chandrasekaran RY. Hou X. Troutman MD. Verhoest PR. Villalobos A. Will Y. ACS Chem. Neurosci.  2010,  1:  420 
    Google Scholar
  • 1c Wager TT. Hou X. Verhoest PR. Villalobos A. ACS Chem. Neurosci.  2010,  1:  435 
    Google Scholar
  • 2 Evans BE. Rittle KE. Bock MG. DiPardo RM. Freidinger RM. Whitter WL. Lundell GF. Veber DF. Anderson PS. J. Med. Chem.  1988,  31:  2235 
    CrossrefPubMedGoogle Scholar
  • 3 de Sá Alves FR. Barreiro EJ. Fraga CAM. Mini-Rev. Med. Chem.  2009,  9:  782 
    Google Scholar
  • 4a Richter HGF. Adams DR. Benardeau A. Bickerdike MJ. Bentley JM. Blench TJ. Cliffe IA. Dourish C. Hebeisen P. Kennett GA. Knight AR. Malcolm CS. Mattei P. Misra A. Mizrahi J. Monck NJT. Plancher JM. Roever S. Roffey JRA. Taylor S. Vickers SP. Bioorg. Med. Chem. Lett.  2006,  16:  1207 
    Google Scholar
  • 4b Roever S. Adams DR. Benardeau A. Bentley JM. Bickerdike MJ. Bourson A. Cliffe IA. Coassolo P. Davidson JE. Dourish C. Hebeisen P. Kennett GA. Knight AR. Malcolm CS. Mattei P. Misra A. Mizrahi J. Muller M. Porter RH. Richter H. Taylor S. Vickers SP. Bioorg. Med. Chem. Lett.  2005,  15:  3604 
    Google Scholar
  • 4c Jolidon S, Narquizian R, Norcross RD, Pinard E, and F. Hoffmann-La Roche A.-G., Vernalis Research Limited . inventors; Patent US 2006128713  .  ; Chem. Abstr. , 145, 62927
  • 4d Adams DR, Bentley JM, Davidson J, Duncton MAJ, Porter RHP, and Vernalis Research Limited . inventors; Patent WO  2000044753.  ; Chem. Abstr. 2000, 133, 150579
  • 5 Guandalini L. Martini E. Martelli C. Romanelli MN. Varani K. Farmaco  2005,  60:  99 
    CrossrefGoogle Scholar
  • 6 Wunberg T, Baumeister J, Jeske M, Nell P, Nikolic S, Suessmeier F, Zimmermann H, Grosser R, Henninger K, Hewlett G, Keldenich J, Lang D, and Bayer Healthcare AG . inventors; Patent WO 2004099212  Germany.  ; Chem. Abstr. 2005, 141, 424207
  • 7 Robichaud A, Mitchell IS, and Bristol-Myers Squibb Pharma Company . inventors; Patent WO  2002059082.  ; Chem. Abstr. 2002, 137, 119688
  • 8 Duggan ME, Egbertson S M, Hartman GD, Young SD, Ihle NC, and Merck and Co., Inc. . inventors; US Patent  5854245.  ; Chem. Abstr. 1999, 130, 81526
  • 9 Jolidon S, Narquizian R, Norcross RD, Pinard E, and Hoffman-La Roche Inc. . inventors; US Patent  20060128713.  ; Chem. Abstr. 2006, 145, 62927
  • 10 Krogsgaard-Larsen N. Jensen AA. Kehler J. Bioorg. Med. Chem. Lett.  2010,  20:  5431 
    CrossrefGoogle Scholar
  • 11 Nijhuis WHN. Verboom W. El-Fadl AA. Harkema S. Reinhoudt DN. J. Org. Chem.  1989,  54:  199 
    CrossrefGoogle Scholar
  • 12 Jiang W. Chen C. Marinkovic D. Tran JA. Chen CW. Arellano LM. White NS. Tucci FC. J. Org. Chem.  2005,  70:  8924 
    CrossrefGoogle Scholar
  • 13 Nielsen SF. Larsen M. Boesen T. Schønning K. Kromann H. J. Med. Chem.  2005,  48:  2667 
    CrossrefGoogle Scholar
  • 14 Watthey JWH. Gavin T. Desai M. Finn BM. Rodebaugh RK. Patt SL. J. Med. Chem.  1983,  26:  1116 
    CrossrefGoogle Scholar
  • 15 Doyle MP. Duffy R. Ratnikov M. Zhou L. Chem. Rev.  2010,  110:  704 
    CrossrefPubMedGoogle Scholar
  • 16 Davies HML. Manning JR. Nature  2008,  451:  417 
    CrossrefGoogle Scholar
  • 17 Doyle MP. McKervey MA. Ye T. Modern Catalytic Methods for Organic Synthesis with Diazo Compounds. From Cyclopropanes to Ylides   Wiley; New York: 1998. 
    Google Scholar
  • 18 Aller E. Brown DS. Cox GG. Miller DJ. Moody CJ. J. Org. Chem.  1995,  60:  4449 
    CrossrefGoogle Scholar
  • 19 Isolated as a clear colorless oil. Analytical data consistent with literature: Ziegler FE. Jeroncic LO. J. Org. Chem.  1991,  56:  3479 
    CrossrefGoogle Scholar
  • 20 Isolated as a clear colorless oil. Analytical data were consistent with literature values: Bytschkov I. Siebeneicher H. Doye S. Eur. J. Org. Chem.  2003,  15:  2888 
    Google Scholar
  • 21 Demonceau A. Noels AF. Hubert AJ. Teyssié P.
    J. Chem. Soc., Chem. Commun.  1981,  688 
    CrossrefGoogle Scholar
  • 22 Sivaguru RJ. Sunoj TWB. Origane Y. Inoue Y. Ramamurthy V. J. Org. Chem.  2004,  69:  6533 
    CrossrefGoogle Scholar
  • 23 Addition and Elimination Reactions of Aliphatic Compounds, In Comprehensive Chemical Kinetics   Vol. 9:  Bamford CH. Tipper CFH. Elsevier; Amsterdam: 1973. 
    Google Scholar